Robert K Y Cheng - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Chemmedchem|March 21, 2009

Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.

Nature|April 27, 2017

Structural insight into allosteric modulation of protease-activated receptor 2Robert K Y Cheng, Cédric Fiez-Vandal, Oliver Schlenker, et al.

Journal of Medicinal Chemistry|January 10, 2012

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's diseaseMichael E Prime, Ole A Andersen, John J Barker, et al.

Journal of Medicinal Chemistry|August 22, 2024

Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo EfficacyJason W Skudlarek, Andrew J Cooke, Helen J Mitchell, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Chemmedchem|March 21, 2009

Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.

Nature|April 27, 2017

Structural insight into allosteric modulation of protease-activated receptor 2Robert K Y Cheng, Cédric Fiez-Vandal, Oliver Schlenker, et al.

Journal of Medicinal Chemistry|January 10, 2012

Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's diseaseMichael E Prime, Ole A Andersen, John J Barker, et al.

Journal of Medicinal Chemistry|August 22, 2024

Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo EfficacyJason W Skudlarek, Andrew J Cooke, Helen J Mitchell, et al.

Pageof 2